Acrivon Therapeutics Inc (ACRV) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Acrivon Therapeutics Inc   (NASDAQ: ACRV)


Acrivon Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Acrivon Therapeutics Inc's ROI in the second quarter of 2026?
Acrivon Therapeutics Inc recorded a cumulative net loss of $-74 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -67.56%.

Within the Healthcare sector 544 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3293 to 3837.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -36.05 % -36.11 % -22.2 % -5.78 % 15 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 98 97 114 130 145
Return On Investment (TTM) -67.56 % -63.54 % -56.41 % -52.94 % -50.03 %
ACRV's Overall Ranking # 3837 # 3293 # 3057 # 2761 # 2959
Seq. Investment Change TTM -9.65 % -11.95 % -10.57 % -10.11 % -9.74 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -74 -77 -78 -82 -86

ACRV Company Profile >> Back to ACRV Roi Comparisons >> See Annual ACRV Return On Investment



Return On Investment ACRV's Ranking
Within: No.
Industry # 241
Sector # 545
Overall # 3837

Return On Investment Statistics
High Average Low
-28.17 %
-45.87 %
-67.56 %
(Mar 31 2023)   (Jun 30 2026)







Financial Statements
Acrivon Therapeutics Inc's II. Quarter Investments $ 98 Millions ACRV's Balance sheet
Acrivon Therapeutics Inc's II. Quarter Income $ -18 Millions Quarterly ACRV's Income Statement
ACRV's Income by Division See ACRV's Income by Division


ACRV Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022
Total Investments in Millions 114 179 125 175 0
Y / Y Investment Growth -36.42 % 43.54 % -28.47 % - -
Net Income in Millions -78 -81 -60 -31 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -68.31 % -44.91 % -48.33 % -17.84 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ACRV's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ACRV's Competitors
Subscribers only: Roi for Acrivon Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for ACRV's Customers

Other Ratios
ACRV's Roa ACRV's Inventory Turnover Ratio ACRV's Growth Rates ACRV's Dividend Statistics
ACRV's Profitability Ratios ACRV's Asset Turnover Ratio ACRV's Dividend Growth
ACRV's Roe ACRV's Valuation Ratios ACRV's Financial Strength Ratios ACRV's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T15:39:09+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.